Divi's Laboratories Limited (DIVISLAB) — Financial Results Announcement

· NSE 🔴 High Importance Neutral
📢 Key Event
Audio recording of Q4 FY26 earnings conference call made available
💡 Investor Takeaway
The call recording is now accessible for review on the company's website.

Divi's Laboratories announced that the audio recording of its Q4 FY26 earnings conference call held on May 23, 2026, is now available on its website under the investors relations section. The filing confirms the call took place at 14:30 Hrs. IST and references compliance with SEBI Regulation 30. No financial results or forward-looking statements were included in the announcement.

📄 View Original Announcement (PDF)

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.